Mikael S Thomsen

This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 5 EPO patents. Top assignees: Saniona A/s, Contera Pharma Aps, Conrig Pharma Aps. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikael S Thomsen. Retrieved from https://idiyas.com/inventor/mikael-s-thomsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 8(Granted Patents)

Location History:

Hridovre, DK (2019)
Hvidovre, DK (2015 - 2024)

Company Filing History:

Years Active: 2015-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12016840 - Tesofensine and beta blocker combination formulations (2024-06-25),

2. 11690814 - Suplatast tosilate for use in the treatment of cough associated with interstitial lung disease (2023-07-04),

3. 11478476 - Use of buspirone metabolites (2022-10-25),

4. 11426383 - Tesofensine and beta blocker combination formulations (2022-08-30),

5. 10828278 - Tesofensine and beta blocker combination formulations (2020-11-10),

6. 10632116 - Combinations of serotonin receptor agonists for treatment of movement disorders (2020-04-28),

7. 10561618 - Orally available pharmaceutical formulation suitable for improved management of movement disorders (2020-02-18),

8. 10537551 - Tesofensine and beta blocker combination formulations (2020-01-21),

9. 10231951 - Tesofensine, beta blocker combination formulation (2019-03-19),

10. 9579288 - Tesofensine and beta blocker combination formulations (2017-02-28),

11. 9186359 - Combinations of serotonin receptor agonists for treatment of movement disorders (2015-11-17),

Title: The Innovative Contributions of Mikael S Thomsen

Introduction

Mikael S Thomsen is a notable inventor based in Hvidovre, Denmark. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work focuses on developing innovative formulations that address various medical conditions.

Latest Patents

Among his latest patents are two noteworthy inventions. The first is a controlled release formulation that combines the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol. This invention is aimed at treating diabetes, obesity, or obesity-associated disorders. The second patent involves a composition comprising suplatast tosilate, which is intended for treating cough associated with interstitial lung disease, including conditions like pulmonary fibrosis.

Career Highlights

Mikael has worked with several companies throughout his career, including Saniona A/S and Contera Pharma ApS. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical formulations.

Collaborations

Mikael has collaborated with notable professionals in his field, including Peter G Nielsen and Bent Højgaard. These partnerships have further enhanced his research and development efforts.

Conclusion

Mikael S Thomsen's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through his inventive formulations. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.